PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset
Presentation Product Chemical substance Chapter Items dispensed
Blissel 50micrograms/g vaginal gel with applicator
0702010F0BEAAAF
Blissel Estriol Obstetrics, Gynaecology and Urinary-Tract Disorders 9,469
Combodart 0.5mg/0.4mg capsules
0704010V0BBAAAA
Combodart Tamsulosin and dutasteride hydrochloride Obstetrics, Gynaecology and Urinary-Tract Disorders 9,393
Tolterodine 2mg modified-release capsules
0704020N0AAAIAI
Tolterodine Tolterodine Obstetrics, Gynaecology and Urinary-Tract Disorders 9,241
Mercilon 150microgram/20microgram tablets
0703010E0BCAAAB
Mercilon Combined ethinylestradiol 20mcg Obstetrics, Gynaecology and Urinary-Tract Disorders 9,066
Levonorgestrel 1.5mg tablets
0703050A0AAABAB
Levonorgestrel (Emergency Contraception) Levonorgestrel Obstetrics, Gynaecology and Urinary-Tract Disorders 8,851
Ethinylestradiol 30microgram / Desogestrel 150microgram tab
0703010F0AAAAAA
Combined ethinylestradiol 30mcg Combined ethinylestradiol 30mcg Obstetrics, Gynaecology and Urinary-Tract Disorders 8,845
Norgeston 30microgram tablets
0703021L0BCAAAA
Norgeston Levonorgestrel Obstetrics, Gynaecology and Urinary-Tract Disorders 8,668
Etonogestrel 68mg implant
0703022P0AAAAAA
Etonogestrel Etonogestrel Obstetrics, Gynaecology and Urinary-Tract Disorders 8,530
Canesten Combi 500mg pessary and 2% cream
0702020F0BBAKAK
Canesten (Vaginal) Clotrimazole Obstetrics, Gynaecology and Urinary-Tract Disorders 8,529
Ethinylestradiol 35microgram / Norgestimate 250microgram tab
0703010G0AAACAC
Combined ethinylestradiol 35mcg Combined ethinylestradiol 35mcg Obstetrics, Gynaecology and Urinary-Tract Disorders 8,166
Yacella 0.03mg/3mg tablets
0703010F0CFAAAJ
Yacella Combined ethinylestradiol 30mcg Obstetrics, Gynaecology and Urinary-Tract Disorders 7,690
Estriol 50micrograms/g vaginal gel with applicator
0702010F0AAAFAF
Estriol (Vaginal) Estriol Obstetrics, Gynaecology and Urinary-Tract Disorders 7,541
Femodene tablets
0703010F0BJAAAE
Femodene Combined ethinylestradiol 30mcg Obstetrics, Gynaecology and Urinary-Tract Disorders 7,494
Tolthen XL 4mg capsules
0704020N0BJABAC
Tolthen XL Tolterodine Obstetrics, Gynaecology and Urinary-Tract Disorders 7,396
Clindamycin 2% vaginal cream
0702020E0AAAAAA
Clindamycin phosphate (Vaginal) Clindamycin phosphate Obstetrics, Gynaecology and Urinary-Tract Disorders 7,212
Ethinylest 33.9microg/Norelgestromin 203microg/24hours ptch
0703010E0AAAEAE
Combined ethinylestradiol 20mcg Combined ethinylestradiol 20mcg Obstetrics, Gynaecology and Urinary-Tract Disorders 7,202
Indoramin 20mg tablets
0704010M0AAAAAA
Indoramin Indoramin Obstetrics, Gynaecology and Urinary-Tract Disorders 7,013
Cialis 20mg tablets
0704050R0BBABAB
Cialis Tadalafil Obstetrics, Gynaecology and Urinary-Tract Disorders 6,739
Mariosea XL 4mg capsules
0704020N0BDAAAC
Mariosea XL Tolterodine Obstetrics, Gynaecology and Urinary-Tract Disorders 6,624
Vardenafil 10mg tablets
0704050AAAAABAB
Vardenafil Vardenafil Obstetrics, Gynaecology and Urinary-Tract Disorders 6,577
Clotrimazole 10% vaginal cream
0702020F0AAAGAG
Clotrimazole (Vaginal) Clotrimazole Obstetrics, Gynaecology and Urinary-Tract Disorders 5,877
Ulipristal 30mg tablets
0703050B0AAAAAA
Ulipristal acetate (Emergency Contraceptive) Ulipristal acetate (Emergency Contraceptive) Obstetrics, Gynaecology and Urinary-Tract Disorders 5,506
Potassium citrate mixture
0704030G0AAAAAA
Potassium citrate Potassium citrate Obstetrics, Gynaecology and Urinary-Tract Disorders 5,476
Caverject 20microgram inj vials
0704050B0BBAAAA
Caverject Alprostadil Obstetrics, Gynaecology and Urinary-Tract Disorders 5,358
Neditol XL 2mg capsules
0704020N0BFABAI
Neditol XL Tolterodine Obstetrics, Gynaecology and Urinary-Tract Disorders 5,336

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.